Drawing for NOVAJECT

USPTO serial 79122580

NOVAJECT

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
STRUCK, ROBERT J
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOVAJECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ann Lamport Hammitte

Ann Lamport Hammitte Lando & Anastasi, LLPOne Main Street, 11th FloorCambridge, MA 02142UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Syringes sold filled with TNF (tumor necrosis factor), epinephrine, glucagon, atropine or benzodiazepine; injectors sold filled with TNF (tumor necrosis factor), epinephrine, glucagon, atropine or benzodiazepine; syringes sold filled with interferon, interleukin, triptan, growth factor hormone for the treatment of growth deficiency, clotting factor for the treatment of bleeding disorders or growth factor antagonist for the treatment of acromegaly; injectors sold filled with interferon, interleukin, triptan, growth factor for the treatment of growth deficiency, clotting factor for the treatment of bleeding disorders or growth factor antagonist for the treatment of acromegaly; syringes sold filled with biological drugs for the treatment of immunological disease and cancer; injectors sold filled with biological drugs for the treatment of immunological disease and cancer; injectors sold filled with insulin; pharmaceutical and veterinary preparationsSECTION 70 - CANCELLED—
010Medical fluid injectors; disposable syringes; disposable injectors; hypodermic syringes; hypodermic injectors; injection syringes (syringe barrels); medical syringes; medical injectors; syringes for medical purposes and for injectors; injectors for medical purposes and for injections; autoinjectors for medical purposes and for injections; medical and veterinary apparatus and instrumentsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 29, 2023UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
Feb 20, 2023DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Feb 19, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 1, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 11, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 2, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 29, 2014FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 12, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 12, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 12, 2013MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 12, 2013ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 15, 2013CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jul 13, 2013CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jul 3, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 3, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 8, 2013RFNTREFUSAL PROCESSED BY IB—
Jan 11, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 11, 2013RFRRREFUSAL PROCESSED BY MPU—
Jan 9, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 8, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 3, 2013DOCKASSIGNED TO EXAMINER—
Jan 3, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2013LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 27, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance